Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 175.60
+0.30 (0.17%)
Sep 23, 2026, 4:08 PM HKT
HKG:2637 Market Cap
HKG:2637 has a market cap or net worth of 13.82 billion as of September 23, 2026.
Market Cap
13.82B
Enterprise Value
12.27B
Revenue
685.64M
Ranking
n/a
PE Ratio
76.17
Stock Price
175.60
ChartMarket Cap Chart
Since October 20, 2025, HKG:2637's market cap has increased from 8.20B to 13.82B, an increase of 68.52%. That is a compound annual growth rate of 75.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 13.82B | 29.12% |
| Dec 31, 2025 | 10.70B | 30.52% |
| Oct 20, 2025 | 8.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| China Resources Pharmaceutical Group | 27.52B |
| China Medical System Holdings | 27.08B |
| Sunshine Lake Pharma | 22.53B |
| Grand Pharmaceutical Group | 17.53B |
| The United Laboratories International Holdings | 16.06B |
| CanSino Biologics | 13.45B |
| Consun Pharmaceutical Group | 11.62B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |